A Real-World Evidence-Based Study of Long-Term Tyrosine Kinase Inhibitors Dose Reduction or Discontinuation in Patients with Chronic Myeloid Leukaemia

Colaboración

Año: 2023

Roldán, AM; Suárez, MDS; Alarcón-Payer, C; Morales, AJ; Puerta, JMP

Título: PHARMACEUTICS

• Q1